Your browser doesn't support javascript.
loading
The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome.
LaBella, Dominic; Regan, Samuel; Konig, Heiko; Egan, Daniel N; Bailey, Neil A; Mawad, Raya; Gilbert, Morgan; Pagel, John M; Pu, Jeffrey J.
Afiliación
  • LaBella D; Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY, United States.
  • Regan S; Department of Radiation Oncology, Duke University, Durham, NC, United States.
  • Konig H; Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY, United States.
  • Egan DN; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
  • Bailey NA; Department of Medicine, Swedish Medical Center, Seattle, WA, United States.
  • Mawad R; Department of Medicine, Swedish Medical Center, Seattle, WA, United States.
  • Gilbert M; Department of Medicine, Swedish Medical Center, Seattle, WA, United States.
  • Pagel JM; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
  • Pu JJ; Department of Medicine, Swedish Medical Center, Seattle, WA, United States.
Front Oncol ; 12: 911745, 2022.
Article en En | MEDLINE | ID: mdl-35992790
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos